RaNA Therapeutics Seeks Medical Treasure In “Junk” RNA
This article was originally published in Start Up
Executive Summary
RaNA Therapeutics, with its new and experienced CEO plus deep talent at the research bench, may well have a bright future before it. But the fact that its drug candidates are oligonucleotides is likely to keep industry observers cautious until more data come in.